Company
Investment-firm
Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Sub-Organizations4
Novartis Consumer Health GmbH
Novartis Consumer Health in Munich sells OTC and prescription drugs for self-medication.
Sector
Subsector
Location
Novartis Oncology
Novartis Oncology is a global company developing innovative medicines to transform the lives of cancer patients worldwide.
Sector
Subsector
Keywords
Location
Sandoz International
Sandoz International is a global leader in generic pharmaceuticals and biosimilars.
Sector
Subsector
Keywords
Location
total rounds
total raised
Similar Companies1000
Novartis
Novartis is a healthcare company that provides solutions to patients' evolving needs.
Sector
Subsector
Keywords
Location
OPEN Health
OPEN Health provides innovative healthcare solutions to improve health outcomes and patient well-being.
Sector
Subsector
Location
Temedica
Temedica is a digital health company that puts the patient at the centre of healthcare.
Sector
Subsector
Keywords
Location
total rounds
total raised
Axios Foundation
Axios International develops healthcare solutions for patient access challenges in emerging markets.
Sector
Subsector
Location
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 19.06.2024. Their latest round Post-IPO Debt
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is a philanthropic organization.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Investments53
Dren Bio
Dren Bio engineers proteins to fight disease.
Sector
Subsector
Location
total rounds
total raised
Catalym
CatalYm is a biopharmaceutical company that develops immunotherapies to treat cancer.
Sector
Subsector
Location
total rounds
total raised
Northern Yiheng
Northern Yiheng produces semiconductor graphite fiber insulation materials.
Sector
Subsector
total rounds
Co-Investors
Investors1
Number of lead investors
Number of investors
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is a philanthropic organization.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Acquisitions29
Mariana Oncology acquired by Novartis
acquirer
date
type
Mariana Oncology
Mariana Oncology is developing targeted radiopharmaceuticals for solid tumors.
Sector
Subsector
Keywords
total rounds
total raised
DTx Pharma acquired by Novartis
acquirer
date
type
price
DTx Pharma
DTx Pharma develops RNA-based therapeutics for personalized treatment across various therapeutic areas.
Sector
Subsector
Location
total rounds
total raised
Chinook Therapeutics acquired by Novartis
acquirer
date
type
price
Chinook Therapeutics
Chinook Therapeutics is a biotechnology company specializing in developing precision medicines for kidney diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Exits3
Aduro BioTech
Aduro BioTech develops and sells therapies that use the body's immune system to treat diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Lumenos
Lumenos provides healthcare accounts, information, services, and incentives to promote informed health decisions and healthy behaviors.
Sector
Subsector
Keywords
Location
total rounds
total raised
IFM Therapeutics
IFM Therapeutics develops medicines that target the innate immune system to treat inflammatory and autoimmune disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
Joerg Reinhardt
Joerg Reinhardt has been Chairman of the Board of Directors of Novartis AG since August 2013. He also serves as Chairman of the Research & Development Committee and as Chairman of the Board of Trustees of the Novartis Foundation. Reinhardt previously served as chairman of the board of management and the executive committee of Bayer HealthCare, Germany. Prior to that, he served as Chief Operating Officer of Novartis from 2008 to 2010, and as Head of the Vaccines and Diagnostics Division of Novartis from 2006 to 2008. He also served as Chairman of the Board of the Genomics Institute of the Novartis Research Foundation in the United States from 2000 to 2010, as a member of the supervisory board of MorphoSys AG in Germany from 2001 to 2004, and as a member of the board of directors of Lonza Group AG in Switzerland from 2012 to 2013. Reinhardt graduated with a Ph.D. in pharmaceutical sciences from Saarland University in Germany. He joined Sandoz Pharma Ltd. in 1982 and held various positions at Sandoz and later Novartis, including Head of Development.
current job
organization founded
Joerg Reinhardt
Employee Profiles381
Isabelle Lindenmayer
Head, Access Center of Excellence
Cristina Campos
Global Health, Head Integrated Access Programs & Markets & Country President Novartis Portugal
Adama Ibrahim
Director, Digital Solutions (Global Drug Development)
Activity
Recent News140
The graph reveals the ratio (%) of positive news articles in a chosen time range